Rep. Troy Balderson (R-OH) (Photo by Michael Brochstein/Sipa USA)(Sipa via AP Images)
August 2, 2023 03:05 PM EDT
FDA+
Manufacturing

Rep­re­sen­ta­tives con­cerned over DSC­SA im­ple­men­ta­tion and sup­ply chain dis­rup­tion

Tyler Patchen

News Reporter

A group of bi­par­ti­san mem­bers of Con­gress, spear­head­ed by Reps. Troy Balder­son (R-OH) and Ann Kuster (D-NH), sent a let­ter to FDA Com­mis­sion­er Rob Califf …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

A service from the Financial Times